Using Biologic Therapy to Treat Cancer

Our Biologic Therapy Program is Internationally recognized for contributions to the biologic treatment of cancer using cytokines (IL-2,1 FN), targeted immunotherapy (CTLA4 and PD1 antibodies), vaccines and other novel agents. Our Biologic Therapy Program specialists, including Drs. David McDermott, James Mier and Rupal Bhatt, investigate and use biologic agents, such as cytokines and vaccines, to treat patients with advanced melanoma and kidney cancer.

More About Us Meet Our Team

More About Biologic Therapy

Biologic Therapy Clinical Trials

Our program conducts pivotal clinical trials that have led to FDA approval for therapies for metastatic kidney cancer and melanoma (skin cancer). 

Biologic Therapy Research

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Tempora doloremque distinctio cum rem quasi odit quia eius nesciunt eaque.

Prepare for Your Visit

To help you prepare for your first visit to our Cancer Center's Biologic Therapy Clinic, read these FAQs on what to expect. 

Request an Appointment

Ready to get started? Call or go online today.

P 1-800-667-5356